Table 4 Medians (inter-quartile ranges) of outcome measures, before and after PBM treatment for group B (n = 6)

On enrolment

Before PBM treatment

After 4 weeks PBM treatment

After 12 weeks PBM treatment

 10MWT walk speed (m/s)

1.21 (0.24)

1.82 (0.30)*

1.94 (0.28)*

1.93 (0.27)

 10MWT stride length (m)

0.52 (0.09)

0.67(0.11)

0.71 (0.08)

0.70 (0.08)

 TUG (s)

7.9 (1.6)

7.4 (1.4)*

6.6 (0.8)*

6.9 (1.1)

 TUG motor (s)

8.6(1.2)

8.2 (1.4)

7.1 (0.7)

6.9 (1.4)

 TUG cognitive (s)

9.6 (1.8)

7.5 (1.1)

7.0 (1.3)*

6.8 (1.3)

 Step test - affected leg (n)

10.0 (4.3)

14.0 (2.0)*

15.0 (2.3)

15.5 (4.0)

 Step test - unaffected leg (n)

11.5 (1.8)

12.5 (3.3)

15.0 (2.3)

16.0 (5.0)

 MoCA

26.0 (2.3)

27.5 (2.5)

28.0 (1.5)

29.0 (1.5)

 NHPT - affected hand (s)

24.6 (6.3)

22.5 (7.0)

24.0 (4.1)

26.0 (9.7)

 NHPT - unaffected hand (s)

22.1 (2.1)

25.4 (7.2)

23.9 (4.7)

24.0 (6.9)

 Spiral test - dominant hand (s)

35.2 (4.4)

33.9 (10.9)

27.3 (10.6)

29.0 (6.2)

 TS affected leg behind (s)

2.0 (3.0)

5.6 (6.2)

19.5 (24.2)*

5.8 (10.6)

 TS unaffected leg behind (s)

1.0 (3.0)

4.2 (7.0)

3.2 (20.3)

2.3 (13.6)

 SLS affected leg raised (s)

1.5 (1.8)

1.6 (1.0)

1.2 (1.2)

0.8 (4.5)

 SLS unaffected leg raised (s)

1.0 (0.8)

2.1 (1.8)

0.1 (1.2)

0.9 (4.8)